Recombinant Human Antibody (268-D) Fab Fragment is specific to HIV-1 gp160, expressed in mammalian cells. It can neutralize human anti-V3, a strain-restricted mAb 268-D. The mAb was selected with a 23-mer V3 peptide of the MN strain, and its binding and neutralizing capacity is limited to HIV-1 strain MN. As V3 residues Lys305, His308 and Arg315 are among the most variable residues in the V3 crown, specificity for their side chains makes mAb 268-D highly strain specific.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
PABL-382 | Human Anti-HIV-1 gp160 Recombinant Antibody (clone VRC08) | Neut, FuncS | Human IgG, κ |
MRO-3753CQ | Human Anti-HIV-1 gp160 Recombinant Antibody (clone 69D2/A1) | WB | Human IgG2, κ |
MRO-3754CQ | Human Anti-HIV-1 gp160 Recombinant Antibody (clone RV110026) | ELISA, WB | Human IgG |
MRO-3755CQ | Human Anti-HIV-1 gp160 Recombinant Antibody (clone 989-D) | ELISA | Human IgG |
MRO-3756CQ | Human Anti-HIV-1 gp160 Recombinant Antibody (clone m66S28LCH) | Neut | Human IgG1 |
There are currently no Customer reviews or questions for PFBW-163. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.